Table 4. Univariate validation in the GSE25204+GSE73582 cohort.
HR | 95% CI | P-value | |
---|---|---|---|
OS | |||
miR-1183 | 0.93 | 0.81–1.07 | 0.311 |
miR-126-3p | 0.85 | 0.63–1.15 | 0.288 |
miR-198 | 0.97 | 0.88–1.08 | 0.593 |
miR-23a-5p | 0.93 | 0.70–1.24 | 0.629 |
miR-23a-3p | 0.89 | 0.69–1.15 | 0.374 |
miR-27a-5p | 1.16 | 0.95–1.41 | 0.148 |
miR-451a | 0.93 | 0.78–1.10 | 0.399 |
miR-483-5p | 1.09 | 0.97–1.23 | 0.158 |
miR-665 | 0.94 | 0.70–1.26 | 0.673 |
TTP | |||
miR-125a-3p | 1.06 | 0.93–1.21 | 0.376 |
miR-126-3p | 1.18 | 0.95–1.47 | 0.129 |
miR-138-5p | 1.18 | 0.99–1.41 | 0.066 |
miR-139-3p | 1.20 | 1.01–1.43 | 0.035 |
miR-23a-5p | 1.35 | 1.13–1.63 | 0.001 |
miR-23a-3p | 1.11 | 0.92–1.34 | 0.292 |
miR-27a-5p | 1.22 | 1.04–1.42 | 0.012 |
miR-27a-3p | 1.04 | 0.87–1.25 | 0.633 |
miR-619-3p | 1.04 | 0.91–1.20 | 0.540 |
miR-665 | 1.36 | 1.10–1.68 | 0.004 |
miR-802 | 1.01 | 0.82–1.25 | 0.923 |
OS = overall survival, HR = hazard ratio, CI = confidence interval, TTP = time to progression. Significant p-values are marked in bold.